Inflammation as a Predictor in Cardioversion of Atrial Fibrillation
Completed
- Conditions
- Atrial Fibrillation
- Interventions
- Procedure: Cardioversion
- Registration Number
- NCT00590525
- Lead Sponsor
- Creighton University
- Brief Summary
The laboratory test, C-Reactive Protein (CRP), has become well established as a marker of inflammation. Recently a high CRP level (indicating an increase in inflammation) was identified as a risk factor for atrial fibrillation. We are conducting this study with patients such as yourself with atrial fibrillation who are planning to undergo cardioversion to determine what sort of relationship exists between CRP levels and atrial fibrillation. We will then look at success rates of converting atrial fibrillation to normal sinus rhythm, compared to patients' CRP levels.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 1 Cardioversion -
- Primary Outcome Measures
Name Time Method We hypothesize that a higher hsCRP is associated with higher failure rates in patients undergoing cardioversion for atrial fibrillation 1 month
- Secondary Outcome Measures
Name Time Method secondary endpoint will be if a new inflammatory disease state is diagnosed at the one-month mark. 1 month
Trial Locations
- Locations (1)
Creighton University Medical Center
🇺🇸Omaha, Nebraska, United States